[go: up one dir, main page]

DK1667665T3 - Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler - Google Patents

Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler

Info

Publication number
DK1667665T3
DK1667665T3 DK04764591T DK04764591T DK1667665T3 DK 1667665 T3 DK1667665 T3 DK 1667665T3 DK 04764591 T DK04764591 T DK 04764591T DK 04764591 T DK04764591 T DK 04764591T DK 1667665 T3 DK1667665 T3 DK 1667665T3
Authority
DK
Denmark
Prior art keywords
active substance
different
active substances
substance pellets
release profiles
Prior art date
Application number
DK04764591T
Other languages
Danish (da)
English (en)
Inventor
Sergej Anschuetz
Roland Schneider
Original Assignee
Pharmaton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaton Sa filed Critical Pharmaton Sa
Application granted granted Critical
Publication of DK1667665T3 publication Critical patent/DK1667665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK04764591T 2003-09-03 2004-08-28 Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler DK1667665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03019577 2003-09-03
PCT/EP2004/009617 WO2005023229A1 (fr) 2003-09-03 2004-08-28 Capsule contenant des pellets de principe actif presentant differents profils de liberation

Publications (1)

Publication Number Publication Date
DK1667665T3 true DK1667665T3 (da) 2009-05-04

Family

ID=34259144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764591T DK1667665T3 (da) 2003-09-03 2004-08-28 Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler

Country Status (17)

Country Link
US (1) US20050058704A1 (fr)
EP (1) EP1667665B1 (fr)
JP (1) JP4897483B2 (fr)
AT (1) ATE419841T1 (fr)
BR (1) BRPI0413201A (fr)
CA (1) CA2537477C (fr)
CY (1) CY1108950T1 (fr)
DE (1) DE502004008834D1 (fr)
DK (1) DK1667665T3 (fr)
ES (1) ES2317024T3 (fr)
MX (1) MXPA06002316A (fr)
PL (1) PL1667665T3 (fr)
PT (1) PT1667665E (fr)
RU (1) RU2356540C2 (fr)
SI (1) SI1667665T1 (fr)
UA (1) UA87471C2 (fr)
WO (1) WO2005023229A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
KR101148734B1 (ko) * 2003-10-10 2012-07-05 에띠빠흠 징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
DE102006006532B4 (de) 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
US20190083399A9 (en) * 2006-04-03 2019-03-21 Isa Odidi Drug delivery composition
WO2008095263A1 (fr) * 2007-02-09 2008-08-14 Alphapharm Pty Ltd Forme pharmaceutique contenant deux ou davantage de principes actifs pharmaceutiques sous des formes physiques différentes
CA2718571A1 (fr) * 2007-03-12 2008-09-18 Pipex Pharmaceuticals, Inc. Substances medicinales a ingestion orale a base de zinc utiles pour diminuer de maniere sure l'absorption de cuivre libre et les niveaux de cuivre libre
PL3050568T3 (pl) 2007-03-13 2021-06-14 Jds Therapeutics, Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
WO2009002867A2 (fr) 2007-06-26 2008-12-31 Nutrition 21, Inc. Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire
CA2610819A1 (fr) * 2007-12-12 2008-12-02 Multi Formulations Ltd. Particules en gelule
US8445020B2 (en) * 2008-05-19 2013-05-21 Pharmalyte Solutions, Llc High-loading, controlled-release magnesium oral dosage forms and methods of making and using same
WO2010010579A1 (fr) * 2008-07-19 2010-01-28 Lupin Limited Forme galénique unitaire multiple de niacine
US20130011469A1 (en) * 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
CN102038691B (zh) * 2009-10-12 2014-06-11 杭州赛利药物研究所有限公司 一种维生素氨基酸的复合制剂及其制备方法
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
WO2014071176A1 (fr) * 2012-11-02 2014-05-08 Disilvestro Robert Suppléments nutritionnels comportant des substituts de repas et procédés associés
US20150104539A1 (en) * 2013-10-15 2015-04-16 Via Naturally, LLC Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身
WO2018035030A1 (fr) * 2016-08-15 2018-02-22 Corr-Jensen Inc. Principes actifs liposolubles à libération prolongée
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
KR102368654B1 (ko) * 2020-04-17 2022-02-28 주식회사 청안오가닉스 녹차 카테킨을 포함하는 경구용 캡슐
BR112023000264A2 (pt) * 2020-07-09 2023-01-31 Dsm Ip Assets Bv Método para aumentar a população de coprococcus spp. no microbioma intestinal
CN111821266B (zh) * 2020-07-17 2021-09-14 迪沙药业集团有限公司 一种牛磺酸缓释组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50151874A (fr) * 1974-05-16 1975-12-06
JPS50151874U (fr) * 1974-06-01 1975-12-17
JPS5347513A (en) * 1976-10-14 1978-04-28 Meiji Seika Kaisha Ltd Preparation of enzymatic agent
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS5982311A (ja) * 1982-11-04 1984-05-12 Shionogi & Co Ltd セフアレキシン持効性製剤
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
ES2138070T3 (es) * 1992-12-23 2000-01-01 Saitec Srl Proceso para la preparacion de formas farmaceuticas de liberacion controlada y las formas obtenidas de esta manera.
FR2705233B1 (fr) * 1993-05-14 1996-07-12 Atheliapharm Sa Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
IT1283478B1 (it) * 1996-07-22 1998-04-21 Roberto Valducci Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato
EP0886519A1 (fr) * 1996-11-01 1998-12-30 Ilex Oncology, Inc. Formulation a liberation prolongee contenant de la dfmo
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
ES2204517T3 (es) * 1999-02-23 2004-05-01 Yuhan Corporation Composiciones de capsula farmaceutica que contienen loratadina y pseudoefedrina.
WO2000069420A1 (fr) * 1999-05-14 2000-11-23 Coraltis Ltd. Compositions a administration buccale par poussees
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements

Also Published As

Publication number Publication date
PL1667665T3 (pl) 2009-06-30
RU2356540C2 (ru) 2009-05-27
MXPA06002316A (es) 2006-05-19
JP4897483B2 (ja) 2012-03-14
ES2317024T3 (es) 2009-04-16
EP1667665A1 (fr) 2006-06-14
CA2537477A1 (fr) 2005-03-17
BRPI0413201A (pt) 2006-10-03
ATE419841T1 (de) 2009-01-15
UA87471C2 (uk) 2009-07-27
DE502004008834D1 (de) 2009-02-26
RU2006110549A (ru) 2007-10-10
PT1667665E (pt) 2009-02-13
CY1108950T1 (el) 2014-07-02
SI1667665T1 (sl) 2009-06-30
US20050058704A1 (en) 2005-03-17
CA2537477C (fr) 2013-05-14
WO2005023229A1 (fr) 2005-03-17
JP2007504189A (ja) 2007-03-01
EP1667665B1 (fr) 2009-01-07

Similar Documents

Publication Publication Date Title
DK1667665T3 (da) Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler
WO2007067044A3 (fr) Capsules/comprimes contenant des principes actifs modifies
EA200970374A1 (ru) Лечение антиаритмическими средствами и омега-3 жирными кислотами и их комбинированным продуктом
WO2006105306A3 (fr) Compositions renfermant des acides gras et/ou leurs derives et un stabilisateur a basse temperature
NO20043612L (no) Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler
WO2011116139A3 (fr) Compositions pharmaceutiques améliorées et procédés d'administration
WO2003043631A3 (fr) Procede d'identification d'enzymes de ciblage de tumeurs
SG162773A1 (en) Flavonoid compounds and uses thereof
WO2001089571A3 (fr) Methode permettant d'augmenter la biodisponibilite de nutriments et preparations pharmaceutiques renfermant de la tetrahydropiperine et des analogues et derives de tetrahydropiperine
DK1906928T3 (da) Kerner og mikrokapsler egnet til parenteral administration og fremgangsmåder til fremstilling deraf
WO2008011538A3 (fr) Méthodes d'utilisation de flavonoïdes pour améliorer la mémoire
WO2006137069A3 (fr) Saponines de balanites aegyptiaca et utilisations de celles-ci
NO20024237L (no) Farmasöytiske formuleringer
WO2005046727A3 (fr) Capsules gelatineuses molles renfermant de l'ibuprofene
BRPI0408848A8 (pt) Composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
EP1961764A4 (fr) Produit d'addition de chaine de sucres et de peptide et produit pharmaceutique comprenant ce produit en tant que principe actif
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BR0309851A (pt) Processos e formulações para aperfeiçoamento de absorção e biodisponibilidade gastrointestinal de drogas hidrofóbicas
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
WO2005107709A3 (fr) Compositions pharmaceutiques encapsulées de gel souple contenant des ingrédients actifs concentrés
WO2009052942A3 (fr) Stabilisation d'agents thérapeutiques protéiques
NO20043910L (no) Nye aminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
GT200100184A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso.
WO2007009201A3 (fr) Procede permettant d'obtenir des derives synthetiques et semi-synthetiques de lignanes, leurs activites antiparasitaires, preparations pharmaceutiques correspondantes, et methodes therapeutiques utilisant lesdits lignanes pour traiter la parasitose